Merix Pharmaceutical Corporation

Company ID F15000001168 Status Inactive
Merix Pharmaceutical Corporation was incorporated as a Foreign For-profit Corporation on March 17, 2015, with its office address at 18 E. Dundee Rd., 3-204 Barrington, IL 60010. It is registered with the Illinois Secretary of State and is authorized to conduct business in Florida. Squires, Meryl serves as the registered agent. The company's leadership includes Squires, Meryl and Squires, Meryl J. The company is currently inactive. The entity ceased operations on September 23, 2016, after being in business for 1 year, 6 months and 6 days.
Contact
Mail Address
18 E. Dundee Rd., 3-204 Barrington, IL 60010
Email
Unreported
Telephone
Website
Go to website
Social Media
Share on Facebook Share on X Share on LinkedIn

Basic Information

Updated: 2025-07-24
Company Name
Merix Pharmaceutical Corporation
Company ID
F15000001168
Date of Registration
FEI/EIN Number
36-4313444
State
Illinois
Type
Foreign Profit Corporation
Office Address
18 E. Dundee Rd., 3-204 Barrington, IL 60010
Last Event
REVOKED FOR ANNUAL REPORT
Date of Dissolution
2016-09-23
Status
Inactive

Agent Information

Agent Name: Squires, Meryl
Address: 2552 Appaloosa Trail Wellington, FL 33414

Governing Persons

Title:
CHRM
Address: 2 Goose Lake Drive Barrington Hills, IL 60010
Title:
PVST
Address: 2 Goose Lake Drive Barrington Hills, IL 60010

Latest Activity & Filing History

Latest Activity
timeline icon
Foreign Profit
2015-03-17

Documents

Filling Date
2015-03-17
Download
Description
Foreign Profit

More Companies in This City

Registered in Barrington

Registration Date
2024-08-21
Status
Active
Company Name
Registration Date
2024-09-11
Status
Active
Registration Date
2025-02-12
Status
Active
Corp ELF
We offer business directories for specific countries and regions, providing detailed information on local companies. It helps users find and connect with businesses in various industries, facilitating networking and growth opportunities.
Contact Us
© 2025 Corpelf.com All rights reserved.